Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumorZeta Chow(The Ohio State University), Piotr Rychahou(Markey Cancer Center)Cancer LettersMay 25, 202410.1016/j.canlet.2024.216993Cited by 8SaveCiteExport RISWatch citationsRelated PapersTargeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy|Cancer Research|2022|68PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors|Cells|2021|20